Image shows the Retina UK logo, which has a dark blue background and Retina UK is written in white text with three squares above and below UK.
High quality information on genetic testing and counselling for families affected by inherited sight loss is now available in one place thanks to the launch of an innovative new website, Unlock Genetics (www.RetinaUK.org.uk/genetics). The site aims to increase the level of awareness of genetic testing and genetic counselling amongst people living with inherited sight loss conditions, empowering them to make fully informed decisions about their lives, healthcare and family planning. It provides clear, trustworthy and balanced information and has been developed with significant input from experts in the field and also those who live with inherited sight loss.
Of the 1,000 people who responded to Retina UK’s Sight Loss Survey in 2019, 43% said they were ‘not aware’ of genetic testing or that they were ‘aware of it but it is not available to me’. The charity estimates 85% of its community do not currently have a genetic diagnosis.
Tina Houlihan, Chief Executive of Retina UK said the site aimed to address the issue of a lack of awareness and enable people to make informed choices.
She said: “Far too many of our community are still unaware that genetic testing and counselling is available to them through the NHS – through our new Unlock Genetics website we aim to change this.
“Being diagnosed with an inherited retinal condition often means there is a great deal of uncertainty ahead but, with access to the right information, there are some areas that people can make informed decisions about and have some control over. This includes genetic testing and counselling, which can lead to a more accurate diagnosis, a better understanding of inheritance patterns and the chances of future generations being affected, and even offer the potential to take part in research trials and access treatments in the future.”
Novartis Pharmaceuticals UK, who funded a grant for this project, believe Unlock Genetics will act as a ‘valuable resource’.
“The patient burden is high for those born with inherited retinal dystrophies (IRD) and the debilitating nature of these conditions can place a life-long physical, emotional and financial burden on patients and their families,” said Chinmay Bhatt, Managing Director UK, Ireland & Nordics for Novartis Pharmaceuticals.
“Learning more about the type of IRD via genetic testing can equip patients and their families to better understand their condition and guide disease management together with their clinician. Retina UK’s Unlock Genetics website offers much needed information around the potential benefits of seeking a genetic diagnosis, and we believe it will act as a valuable resource for the community.”
The benefits of those living with an inherited sight loss condition having a genetic diagnosis and accessing genetic counselling can include:
- Feeling better informed about their condition and the reason why they and their family have been affected.
- Being given a more precise diagnosis and a possible indication of how their sight loss might progress.
- Confirmation of inheritance pattern, providing a clear understanding of risks to children and grandchildren and opening up choices around family planning.
- Potentially becoming eligible to participate in the increasing number of clinical trials and being able to access treatments when they become available.